Patient height may not determine optimal glenosphere size for reverse shoulder arthroplasty
Selection of glenosphere size based on patient height did not improve range of motion or patient-reported outcome measures after reverse shoulder arthroplasty, according to published results.
Researchers separated 589 primary reverse shoulder arthroplasties (Equinoxe, Exactech) into groups based on whether patients had a glenosphere size of 38-mm or 42-mm and calculated predictive accuracy in relation to height and sex for predicting glenosphere size. Researchers compared improvements in active range of motion and patient-reported outcome measures, including American Shoulder and Elbow Surgeons score, Constant score, simple shoulder test score and University of California, Los Angeles score, based on glenosphere size as a function of height.
Patient height and sex had a strong association with surgeon selection of glenosphere size, according to results of a logistic regression analysis. Researchers found surgeons preferentially treated patients with shorter heights with 38-mm glenospheres and patients with taller heights with 42-mm glenospheres. However, results showed glenosphere size and patient height had no statistically significant interaction effect on improvements in range of motion or patient-reported outcome measures.
“Surgeons should consider other variables when selecting a particular glenosphere size, as similar clinical improvements can be expected between 38- and 42-mm implants using a lateralized humeral [reverse shoulder arthroplasty] RSA design,” the authors wrote. – by Casey Tingle
Disclosures: Schoch reports he is a paid consultant and receives royalties from Exactech. Please see the study for all other authors’ relevant financial disclosures.